Cencora (NYSE:COR) Shares Gap Down – Should You Sell?

Cencora, Inc. (NYSE:COR)’s share price gapped down prior to trading on Wednesday . The stock had previously closed at $333.87, but opened at $319.59. Cencora shares last traded at $321.3230, with a volume of 178,179 shares.

Key Stories Impacting Cencora

Here are the key news stories impacting Cencora this week:

• Positive Sentiment: Wells Fargo issued a Buy rating on Cencora, providing a fresh bullish signal and potentially supporting the stock’s valuation. Wells Fargo Gives a Buy Rating to Cencora
• Positive Sentiment: Brokerage coverage remains broadly constructive, with Cencora receiving an average “Moderate Buy” rating. Several recent price targets are above the current trading level, and Zacks highlighted the stock as a potential long-term value opportunity. Cencora Receives Moderate Buy Rating Why Cencora Is a Top Value Stock
• Positive Sentiment: Long-term momentum arguments remain intact, supported by Cencora’s healthcare-distribution scale, recurring demand and recent earnings that exceeded consensus expectations for both revenue and adjusted EPS. Why Cencora Is a Top Momentum Stock
• Neutral Sentiment: Analysts focused on customer concentration, pricing changes, GLP-1 demand and the outlook during Cencora’s earnings call. The questions underscore areas investors are monitoring but did not establish a new major catalyst. Five Analyst Questions From Cencora’s Earnings Call
• Neutral Sentiment: Institutional positioning was mixed: 561 investors added shares while 802 reduced holdings. Large purchases by JPMorgan, Morgan Stanley and others were offset by reductions from BlackRock and Royal Bank of Canada, offering no clear consensus signal.
• Negative Sentiment: Revenue-headwind concerns remain the primary pressure on COR. Cencora’s lowered fiscal 2026 revenue-growth outlook reflects WAC and IRA-related price reductions, faster brand conversions at a major mail-order customer, slower GLP-1 growth and customer losses. Analyst target reductions after the outlook reset likely reinforced the recent decline. Cencora Slides as Investors Remain Cautious on Revenue Headwinds

Analyst Ratings Changes

A number of analysts have issued reports on COR shares. Citigroup reaffirmed a “buy” rating on shares of Cencora in a report on Thursday, August 6th. Wall Street Zen raised Cencora from a “hold” rating to a “buy” rating in a research report on Saturday, August 8th. Robert W. Baird set a $370.00 price objective on shares of Cencora in a research note on Thursday, August 6th. Weiss Ratings upgraded shares of Cencora from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Thursday, August 6th. Finally, William Blair assumed coverage on shares of Cencora in a research note on Tuesday, April 28th. They set a “market perform” rating for the company. Thirteen investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $374.25.

Cencora Stock Performance

The firm has a fifty day simple moving average of $298.20 and a 200 day simple moving average of $313.24. The company has a current ratio of 0.93, a quick ratio of 0.58 and a debt-to-equity ratio of 3.53. The stock has a market cap of $60.34 billion, a price-to-earnings ratio of 23.04, a PEG ratio of 1.81 and a beta of 0.57.

Cencora (NYSE:COR) last announced its quarterly earnings data on Wednesday, August 5th. The company reported $4.48 earnings per share for the quarter, topping the consensus estimate of $4.35 by $0.13. The company had revenue of $84.75 billion for the quarter, compared to analyst estimates of $84.31 billion. Cencora had a return on equity of 125.45% and a net margin of 0.79%.Cencora’s revenue for the quarter was up 5.1% compared to the same quarter last year. During the same quarter last year, the firm earned $4.00 EPS. As a group, sell-side analysts expect that Cencora, Inc. will post 17.84 earnings per share for the current year.

Cencora Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Monday, August 31st. Shareholders of record on Friday, August 14th will be paid a dividend of $0.60 per share. The ex-dividend date is Friday, August 14th. This represents a $2.40 dividend on an annualized basis and a yield of 0.8%. Cencora’s payout ratio is currently 17.83%.

Cencora announced that its Board of Directors has initiated a stock buyback plan on Thursday, May 21st that allows the company to repurchase $2.00 billion in outstanding shares. This repurchase authorization allows the company to reacquire up to 3.9% of its shares through open market purchases. Shares repurchase plans are often a sign that the company’s board of directors believes its stock is undervalued.

Insider Activity

In other Cencora news, Director Lauren M. Tyler acquired 550 shares of the company’s stock in a transaction dated Monday, June 22nd. The stock was bought at an average price of $270.23 per share, for a total transaction of $148,626.50. Following the purchase, the director owned 4,359 shares in the company, valued at $1,177,932.57. This represents a 14.44% increase in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. Corporate insiders own 0.38% of the company’s stock.

Institutional Trading of Cencora

A number of institutional investors and hedge funds have recently added to or reduced their stakes in COR. Vanguard Group Inc. boosted its holdings in Cencora by 0.9% during the fourth quarter. Vanguard Group Inc. now owns 23,617,117 shares of the company’s stock valued at $7,976,681,000 after purchasing an additional 221,570 shares in the last quarter. BlackRock Inc. acquired a new position in shares of Cencora in the 2nd quarter worth approximately $5,154,136,000. State Street Corp raised its holdings in shares of Cencora by 1.3% in the 4th quarter. State Street Corp now owns 9,305,507 shares of the company’s stock worth $3,142,935,000 after buying an additional 115,191 shares in the last quarter. T. Rowe Price Investment Management Inc. lifted its position in shares of Cencora by 160.1% during the 4th quarter. T. Rowe Price Investment Management Inc. now owns 6,700,091 shares of the company’s stock worth $2,262,956,000 after buying an additional 4,123,795 shares during the period. Finally, Geode Capital Management LLC lifted its position in shares of Cencora by 3.2% during the 4th quarter. Geode Capital Management LLC now owns 5,459,476 shares of the company’s stock worth $1,843,268,000 after buying an additional 169,055 shares during the period. Institutional investors own 97.52% of the company’s stock.

About Cencora

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.